Blom, Dirk Jacobus
Marais, Adrian David
Moodley, Rajen
van der Merwe, Nico
van Tonder, Alet
Raal, Frederick Johan
Article History
Received: 10 February 2022
Accepted: 31 March 2022
First Online: 23 April 2022
Declarations
:
: Not applicable.
: Not applicable.
: DB reports grants for clinical trials and/or personal fees from Abbott, Akcea, Amgen, Amryt, AstraZeneca, Lib Therapeutics, Novartis, and Sanofi. ADM, RM and NvdM reports no competing interests. AvT is an employee of Novartis South Africa. FJR has received fees for conducting clinical research on inclisiran from The Medicines Company, and has personally received fees from Amgen, Sanofi, Regeneron, Novartis and The Medicines Company for attendance of advisory board meetings and lectures.